NCT05732116 PTSD of Surgeons or Anesthesiologists on Prognosis of Surgical Patients
| NCT ID | NCT05732116 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Xijing Hospital |
| Condition | Post Traumatic Stress Disorder |
| Study Type | OBSERVATIONAL |
| Enrollment | 10,000 participants |
| Start Date | 2023-02-21 |
| Primary Completion | 2025-11-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 10,000 participants in total. It began in 2023-02-21 with a primary completion date of 2025-11-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The objective of this prospective cohort study is to explore the association between the development of post-traumatic stress disorder (PTSD) in surgeons and anesthesiologists and postoperative prognosis in surgical patients they care for during the COVID-19 pandemic. There are 2 cohorts included in this study. The first cohort consists of registered surgeons and anesthesiologists in the study center. The development of PTSD will be evaluated with a series of questionnaires and scales. This cohort defines exposure (with PTSD). The second cohort consists of surgical patients managed by the surgeons and anesthesiologists in the first cohort. The postoperative outcome of these patients will be evaluated thus to explore the association between PTSD in physicians and adverse patient outcomes. The second cohort defines the outcomes( response).
Eligibility Criteria
Inclusion Criteria: * Registered Surgeons and anesthesiologists in the study center Exclusion Criteria: * Surgeons and anesthesiologists with potential practice location changes during the study periods * Refuse to sign written informed consent and fill out the evaluation questionnaire
Contact & Investigator
Chong Lei, MD&phD
PRINCIPAL INVESTIGATOR
Xijing Hospital
Frequently Asked Questions
Who can join the NCT05732116 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Post Traumatic Stress Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05732116 currently recruiting?
Yes, NCT05732116 is actively recruiting participants. Contact the research team at crystalleichong@126.com for enrollment information.
Where is the NCT05732116 trial being conducted?
This trial is being conducted at Ningbo, China, Xi'an, China.
Who is sponsoring the NCT05732116 clinical trial?
NCT05732116 is sponsored by Xijing Hospital. The principal investigator is Chong Lei, MD&phD at Xijing Hospital. The trial plans to enroll 10,000 participants.